BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32959460)

  • 1. Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
    Pedersini R; Fornaro C; di Mauro P; Bianchi S; Vassalli L; Amoroso V; Gelmi M; Ardine M; Rodella F; Cosentini D; Dalla Volta A; Turla A; Pierini M; Motta P; Conti E; Simoncini EL; Berruti A
    Int J Nurs Pract; 2021 Jun; 27(3):e12888. PubMed ID: 32959460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia.
    Mustoe MM; Lee CM; Melisko ME; Esserman LJ; Rugo HS
    Future Oncol; 2018 Oct; 14(24):2461-2469. PubMed ID: 30001151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
    Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
    Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
    Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
    Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
    [No Abstract]   [Full Text] [Related]  

  • 9. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
    Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
    Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
    Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
    Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
    Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
    Munzone E; Bagnardi V; Campennì G; Mazzocco K; Pagan E; Tramacere A; Masiero M; Iorfida M; Mazza M; Montagna E; Cancello G; Bianco N; Palazzo A; Cardillo A; Dellapasqua S; Sangalli C; Pettini G; Pravettoni G; Colleoni M; Veronesi P
    Br J Cancer; 2019 Aug; 121(4):325-331. PubMed ID: 31303642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
    Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
    Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
    Villarreal-Garza C; Mesa-Chavez F; Garza-Ledezma MRA; Peña-Curiel O; Martinez-Cannon BA; Canavati-Marcos M; Cardona-Huerta S
    Breast Cancer Res Treat; 2021 Jan; 185(2):453-458. PubMed ID: 33125621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
    Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
    Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.
    Massey CS
    Eur J Oncol Nurs; 2004 Jun; 8(2):121-30. PubMed ID: 15171971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
    Nomizu T; Ueo H; Kato M; Fukuma E
    Gan To Kagaku Ryoho; 2023 Mar; 50(3):321-325. PubMed ID: 36927900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.